Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat for Cystic Fibrosis
NCT00537602Phase 2Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Nov 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miglustat in cystic fibrosis (CF), sponsored by Actelion Pharmaceuticals Ltd. Started Nov 2007; status: terminated.
02
Drugs
miglustat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00537602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537602.